Breast cancer expression profiling: the impact of microarray testing on clinical decision making (Q36613933)

15 August 2017

1 reference

title

Breast cancer expression profiling: the impact of microarray testing on clinical decision making (English)

1 reference

15 August 2017

1 reference

Olga Modlich

1

1 reference

15 August 2017

Hans-Bernd Prisack

series ordinal

2

1 reference

15 August 2017

Hans Bojar

series ordinal

3

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

Expert Opinion on Pharmacotherapy

15 August 2017

1 reference

15 August 2017

7

1 reference

15 August 2017

15

1 reference

15 August 2017

2069-2078

1 reference

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

15 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Generalization of DNA microarray dispersion properties: microarray equivalent of t-distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Expression of FGF-2 alters focal adhesion dynamics in migration-restricted MDA-MB-231 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Molecular portraits of breast cancer: tumour subtypes as distinct disease entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Different gene expression patterns in invasive lobular and ductal carcinomas of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Prognostic meta-signature of breast cancer developed by two-stage mixture modeling of microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

The impact of expression profiling on prognostic and predictive testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

The molecular portraits of breast tumors are conserved across microarray platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Roadmap for developing and validating therapeutically relevant genomic classifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Using DNA microarrays for diagnostic and prognostic prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Whole genome DNA copy number changes identified by high density oligonucleotide arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Single nucleotide polymorphism array analysis of flow-sorted epithelial cells from frozen versus fixed tissues for whole genome analysis of allelic loss in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

"Good Old" clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Clinical application of molecular profiling in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Predictors of primary breast cancers responsiveness to preoperative epirubicin/cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Prediction of docetaxel response in human breast cancer by gene expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Gene expression profile associated with response to doxorubicin-based therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Molecular classification of breast cancer patients by gene expression profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Immediate gene expression changes after the first course of neoadjuvant chemotherapy in patients with primary breast cancer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.7.15.2069

10.1517/14656566.7.15.2069

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference